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Abstract. 
 
Single endothelial cells (EC) seeded in sus-
pension culture rapidly undergo apoptosis. Addition of 
survival factors, such as VEGF and FGF-2, does not 
prevent apoptosis of suspended EC. However, when 
cells are allowed to establish cellÐcell contacts, they be-
come responsive to the activities of survival factors. 
These observations have led to the development of a 
three-dimensional spheroid model of EC differentia-
tion. EC spheroids remodel over time to establish a dif-
ferentiated surface layer of EC and a center of unorga-
nized EC that subsequently undergo apoptosis. Surface 
EC become quiescent, establish firm cellÐcell contacts, 
and can be induced to express differentiation antigens 
(e.g., induction of CD34 expression by VEGF). In con-
trast, the unorganized center spheroid cells undergo
apoptosis if they are not rescued by survival factors. 
The responsiveness to the survival factor activities of 
VEGF and FGF-2 was not dependent on cell shape 
changes since it was retained after cytochalasin D treat-
ment. Taken together, these findings characterize sur-
vival factor requirements of unorganized EC and indi-
cate that polarized surface EC differentiate to become 
independent of exogenous survival factors. Further-
more, they demonstrate that spheroid cell culture sys-
tems are useful not just for the study of tumor cells and 
embryonic stem cells but also for the analysis of differ-
entiated functions of nontransformed cells.
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E
 
ndothelial 
 
cells (EC)
 
1
 
 are mesenchyme-derived
cells that line the inside of all blood vessels as an
epithelioid monocellular layer. Correspondingly,
endothelial cells can be grown on tissue culture surfaces to
form a monocellular layer of cells that mimics many of the
phenotypic and functional properties of endothelial cells
in vivo (37). Originally isolated from large blood vessels
such as the bovine aorta (45) and the human umbilical
vein (21, 26), EC can now essentially be isolated from any
capillary bed (23, 18) and serially propagated in culture as
nontransformed cells with a finite life span. Bovine aortic
EC (BAEC) have been cultured for 
 
.
 
50 passages (
 
.
 
100
population doublings; reference 5) and human umbilical
vein endothelial cells (HUVEC) can be grown up to 15Ð20
passages (30Ð40 population doublings; reference 32).
EC maintained in standard two-dimensional cell culture
tend to lose many of their differentiated phenotypic prop-
erties that limits the study of differentiated cell functions
in vitro. The distinct organ-specific morphological charac-
teristics of EC (continuous nonfenestrated [brain, lung];
discontinuous with intracellular fenestrae [renal glomeruli,
endocrine glands]; discontinuous with interendothelial
gaps [sinusoids of liver, spleen, and bone marrow]; refer-
ences 6, 41) are gradually lost when EC are propagated in
culture. Cultured brain EC lose their tight junction-depen-
dent bloodÐbrain barrier characteristics (macromolecular
impermeability and high electrical resistance; 54). Like-
wise, EC differentiation antigens such as CD34 are down-
regulated upon transfer of EC in culture (16). Cultured
EC grow to form a confluent monolayer. Nevertheless, es-
tablished two-dimensional EC culture models are not ca-
pable to generate a quiescent, resting EC phenotype in
vitro that corresponds to the very low turnover of EC in
vivo (for review see reference 15).
With the increasing appreciation of the functional and
phenotypic diversity of EC (20), we reasoned that the
study of differentiated endothelial cell functions would re-
quire the development of novel experimental cell culture
systems that reflect the in vivo microenvironment of EC
more closely than standard monolayer culture on plastic
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 BAEC, bovine aortic endothelial cells;
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substrata or the use of nonphysiological matrices (37). Our
search for novel endothelial cell culture and differentia-
tion models was furthermore inspired by recent in vivo ob-
servations that have shed light into the complexity of dif-
ferentiated endothelial cell functions to demonstrate the
requirement of immature EC to be supported by the activ-
ities of survival factors (1, 11).
The search for cell culture systems that facilitate the
study of cell differentiation and the analysis of the activi-
ties of survival factors in a defined microenvironment has
led us to the development of a spheroid model of endothe-
lial cell differentiation. Spheroid models of tumor cells
and embryonic stem cells have been widely used to study
cellular differentiation, cellÐcell interactions, hypoxia re-
sponses, and even in therapeutically oriented studies (7,
29, 31, 36, 49, 52). Few investigators have applied spheroid
cell culture models for the study of differentiated func-
tions of nontransformed cells. However, as shown in this
study a spheroid cell culture model of nontransformed EC
proved to be a powerful tool to study the differentiation of
EC as well as the functions of endothelial survival factors
in a defined experimental system. The data presented in
this study characterize the target cell population of endo-
thelial survival factors and illustrate a differentiation
potential of spheroid EC that goes beyond the degree
of differentiation that can be achieved in standard
two-dimensional culture systems. The experiments sug-
gest that spheroid culture models may be useful not just
for the study of differentiated endothelial cell functions
but also for the analysis of the organotypic differentiation
of other nontransformed cell populations.
 
Materials and Methods
 
Antibodies, Growth Factors, and Reagents
 
FGF-2, TNF-
 
a
 
, and IL-1 (all human recombinant) were obtained from
Promega (Mannheim, Germany). Human recombinant VEGF was from
PAN-Systems (Nrnberg, Germany). Neutralizing (type I) and nonneu-
tralizing (type II) monoclonal mouse antiÐbovine FGF-2 antibody were
purchased from Upstate Biotechnology (Biomol, Hamburg, Germany)
and the neutralizing monoclonal mouse anti-human VEGF antibody was
obtained from R&D Systems GmbH (Wiesbaden, Germany) just as the
polyclonal goat antiÐhuman ICAM-1 and goat antiÐhuman VCAM-1 anti-
bodies. The monoclonal mouse anti-CD34 antibody (clone QBEnd/10)
was purchased from Novocastra Laboratories (Loxo GmbH, Dossenheim,
Germany). The monoclonal mouse anti-CD31 antibody and the mono-
clonal mouse anti-BrdU antibody were from Dako (Glostrup, Denmark).
Cytochalasin D and carboxymethylcellulose were obtained from Sigma
(Deisenhofen, Germany). RGD-containing peptides (GRGDSP) as well
as control RAD-peptides were from Biomol (Hamburg, Germany).
 
Cell Culture
 
Endothelial cell growth medium (ECGM) and endothelial cell growth
supplement (human umbilical vein endothelial cell culture) were pur-
chased from Promocell (Heidelberg, Germany). DME and other cell cul-
ture media were from Life Technologies (GIBCO BRL, Eggenstein, Ger-
many). FCS was obtained from Biochrom (Berlin, Germany). Bovine
aortic EC (BAEC) were isolated from thoracic aortas of healthy cattle by
collagenase digestion following standard protocols. Cells were cultured at
37
 
8
 
C in 75-cm
 
2
 
 tissue culture dishes in DME containing 10% heat-inacti-
vated FCS and frozen in liquid nitrogen at passage 2 or 3. Cells were rou-
tinely split at a 1:5 ratio and cultured 
 
,
 
50 passages. Only BAE cells cul-
tured from passage 15Ð30 were used for experiments. HUVEC were
freshly isolated from human umbilical veins of newborn babies by collage-
nase digestion. Cells were cultured at 37
 
8
 
C in 75-cm
 
2
 
 tissue culture dishes
in ECGM containing 10% heat-inactivated FCS and frozen in liquid nitro-
gen at passage 2 or 3. Only HUVEC cultured from passage 4 to 8 were
used for experiments. Nontransformed bovine esophageal epithelial cells
(KOP) were obtained from Dr. R. Riebe (BFAF, Insel Riems, Germany)
and C6 glioma cells were provided by Dr. G. Breier (MPI, Bad Nauheim,
Germany).
 
Generation of Endothelial Spheroids
 
Confluent monolayers of HUVEC or BAEC were trypsinized. Cells were
suspended in corresponding culture medium containing 20% methocel,
seeded into nonadhesive 75-cm
 
2
 
 bacteriological dishes (Greiner, Fricken-
hausen, Germany), and cultured at 37
 
8
 
C (5% CO
 
2
 
, 100% humidity). Un-
der these conditions suspended EC aggregate spontaneously within 4 h to
form cellular aggregates of varying size and cell number. The methocel
used for these experiments was diluted from a stock solution that was gen-
erated by dissolving 6 g of carboxymethylcellulose in 500 ml of medium
(DME or ECGM basal medium). After centrifugation the clear, gel-like
supernatant was used for experiments. Methocel prevents adhesion of
cells and acts as an inert viscosity modulating substance. Variation of the
methocel concentration during spheroid formation was, thus, used to con-
trol the average size of the spheroids. These multicellular spheroids were
designated as random spheroids and used for all experiments that em-
ployed larger populations of cells. To generate endothelial cell spheroids
of defined size and cell number, a specific number of cells (varying be-
tween 500 and 3,000 cells per spheroid, depending on the experiment) was
suspended in culture medium and seeded in nonadherent round-bottom
96-well plates (Greiner, Frickenhausen, Germany). Under these condi-
tions all suspended cell contribute to the formation of a single endothelial
cell spheroid. These spheroids, designated as standard spheroids, were
harvested within 24 h and used for the corresponding experiments.
 
BrdU Labeling
 
Proliferating cells were labeled by adding BrdU (concentration in me-
dium: 100 
 
m
 
M; Sigma, Deisenhofen, Germany) for 20 h into the culture
medium without changing the medium. Subconfluent cells were labeled 2 d
after seeding. To assess BrdU incorporation into confluent monolayers,
cells were split at a low ratio (1:3), grown to confluence for 2 d to 3 d and
cultured for an additional day after which BrdU was added. BrdU incor-
poration into spheroids was assessed at early time points (1 d) as well as
later time points (BAEC, 7 d; HUVEC, 5 d). Monolayer cells and spher-
oids were processed for paraffin embedding as outlined below.
 
Morphological and Immunohistochemical Analysis
 
Random spheroids or standard spheroids were harvested and centrifuged
for 3 min at 200 
 
g
 
. Cultured monolayer cells were harvested by trypsiniza-
tion and collected by centrifugation. Spheroids and pelleted monolayer
cells were fixed in HBSS containing 4% formaldehyde and processed for
paraffin embedding: after dehydration (graded series of ethanol and iso-
propanol, 1 h each), the specimen were first immersed with paraffin I
(melting temperature 42
 
8
 
C) for 12 h at 60
 
8
 
C. Spheroids and monolayer
cells were again collected by centrifugation and immersed with paraffin II
(melting temperature 56
 
8
 
C) for 12 h at 70
 
8
 
C. Finally, the resulting paraffin
block was cooled to room temperature and trimmed for sectioning. For
histochemical analyses, paraffin sections (3 
 
m
 
m) were cut, deparaffinized,
and rehydrated. Sections were then incubated with 3% H
 
2
 
O
 
2
 
 in H
 
2
 
O to in-
hibit endogenous peroxidase. Antigen retrieval was performed by boiling
the sections in 500 ml of 0.1 M citrate buffer (pH 6.0) in a microwave oven
for 30 min (ICAM-1, VCAM-1) or incubating them in 0.5% Triton X-100
in 2 N HCl (BrdU). After washings in PBS, the sections were incubated
for 30 min with blocking solution (10% normal goat serum [adhesion mol-
ecules]; 0.5% Tween-20 and 0.5% BSA in PBS [BrdU]) followed by incu-
bation with the corresponding primary antibody in a humid chamber at
4
 
8
 
C overnight. They were then incubated with secondary antibody (bio-
tinylated goat antiÐrabbit immunoglobulin or biotinylated goat antiÐ
mouse immunoglobulin antibody; Zymed, San Francisco, CA), exposed to
streptavidin peroxidase, developed with diaminobenzidine as substrate,
and weakly counterstained with methylgreen.
 
Ultrastructural Analysis
 
Spheroids were fixed in KarnovskyÕs fixative, postfixed in 1.0% osmium
tetroxide, dehydrated in a graded series of ethanol, and embedded in
epon. 0.5-
 
m
 
m sections were cut and stained with azure 11 methylene blue
for light microscopic evaluation. Ultrathin sections (50Ð80 nm) were cut, 
Korff and Augustin 
 
Endothelial Cells in Multicellular Spheroids
 
1343
 
collected on copper grids, and automatically stained with uranyl acetate
and lead citrate for observation with a Zeiss EM 10 electron microscope.
 
Detection of Apoptotic Cells in Spheroids
 
Native Spheroids. 
 
Apoptotic and living cells in native spheroids were
stained with two discriminating fluorescence dyes (Live/Dead-Viability/
Cytotoxicity Kit; Molecular Probes, MoBiTec, Gttingen, Germany). 10
standard spheroids were harvested and incubated for 30 min with calcein
AM and ethidiumbromide-homodimer following the manufacturerÕs in-
structions. After centrifugation for 1 min at 500 
 
g
 
, the supernatant was as-
pirated and the spheroids were transferred on a glass slide and analyzed
by confocal laser scanning microscopy (LSM410; Zeiss, Jena, Germany).
 
Fixed Spheroids. 
 
Apoptotic cells were visualized by histochemical de-
tection of nucleosomal fragmentation products (TUNEL) applying the in
situ Cell Death Detection Kit (Boehringer Mannheim, Germany) follow-
ing the manufacturerÕs instructions. In brief, nucleosomal fragmentation
products in sections of paraffin embedded spheroids were detected after
deparaffination and proteinase K digestion by 3
 
9
 
 end labeling with fluo-
rescein-dUTP using terminal deoxynucleotidyl transferase. Labeling was
visualized either directly by fluorescence microscopy or indirectly after in-
cubating the sections with peroxidase labeled anti-fluorescein antibody
and developing with diaminobenzidine as substrate.
 
DNA Fragmentation Assays
 
DNA Laddering. 
 
To assess DNA fragmentation in nonadherent, sus-
pended EC, cells were harvested and pelleted by centrifugation at 13,000 
 
g
 
(4
 
8
 
C) for 20 min. The pellet was diluted in 500 
 
m
 
l 10 mM Tris containing
10 mM EDTA (pH 8.0) and incubated with 20 
 
m
 
g/ml RNase A (Sigma,
Deisenhofen, Germany) for 25 min on ice. Subsequently, 500 
 
m
 
l of 10 mM
Tris containing 10 mM EDTA and 2% SDS (pH 8.0) was added and the
lysate was incubated with 200 
 
m
 
g/ml Proteinase K (Sigma, Deisenhofen,
Germany) at 37
 
8
 
C for 3 h. DNA was extracted by double chloroform/phe-
nol-extraction-method and precipitated overnight in 0.5 M NaCl contain-
ing 50% isopropanol (
 
2
 
70
 
8
 
C). After centrifugation at 13,000 
 
g
 
 for 15 min
at 4
 
8
 
C, the DNA was dissolved in 10 mM Tris containing 10 mM EDTA
(pH 8.0) and analyzed on a 1.6% agarose gel.
 
DNA Fragmentation ELISA. 
 
Quantitation of fragmented DNA was
performed by ELISA (Cell Death Detection Elisa Kit; Boehringer Mann-
heim, Germany). Fragmented DNA of 10 standard spheroids was ex-
tracted by lysis for 60 min at room temperature with vigorous shaking.
The extracts were centrifuged for 10 min at 13,000 
 
g
 
 and 300 
 
m
 
l of the su-
pernatant was incubated with peroxidase-labeled anti-DNA antibody and
biotinylated anti-histone antibody in streptavidin-coated microtiter plates
following the manufacturerÕs instructions. After washing, binding of
mono- and oligonucleosomal DNA was visualized by developing with the
peroxidase substrate ABTS (2,2
 
9
 
-Azino-di[3-ethylbenzthiazolin-sulfonat]).
Plates were analyzed at 405 nm using an automated microtiter plate
reader (EAR 400AT; SLT Lab Instruments, Salzburg, Austria).
 
Results
 
Endothelial Cell Spheroids Form Spontaneously and 
Differentiate Over Time
 
To establish procedures for the generation of stable endo-
thelial cell spheroids, we employed similar techniques that
have been developed for the generation of tumor cell
spheroids. Seeding of suspended EC in nonadhesive tissue
culture dishes led to the formation of multicellular aggre-
gates within 4 h. Depending on the methocel concentra-
tion in the medium, the average size of the resulting endo-
thelial cell spheroids varied from very small aggregates
(
 
,
 
50 cells) to larger aggregates of several thousand cells
with several hundred micrometer in diameter. Routinely,
we used 20% methocel which resulted in the formation
of spheroids with an average diameter between 100 and
300 
 
m
 
m. As an alternative spheroid generation technique,
we seeded a defined number of suspended EC in nonadhe-
sive 96-well round bottom plates. Applying this technique,
essentially all cells seeded in one well contributed to the
formation of a single standardized spheroid (Fig. 1).
Both, random as well as standard spheroids differenti-
ated spontaneously over time if they were maintained in
suspension culture. Within 24 h of spheroid formation, the
cells in the spheroids organized to establish a surface layer
of elongated cells that formed a monolayer and a center of
unorganized cells (Fig. 2 
 
A
 
). Spheroids of EC could be
maintained in suspension culture for several weeks. After
7 d, the unorganized center cells had disappeared and the
endothelial cell spheroids consisted of an almost acellular
core and a surface layer of elongated cells (Fig. 2 
 
B
 
).
To examine if other nontransformed cells differentiate
spontaneously in three-dimensional cell culture systems,
we formed spheroids of esophageal epithelial (KOP) cells.
These cells grow in two-dimensional cell culture to form a
growth arrested monolayer. Like EC, spheroids of KOP
cells form multicellular aggregates in suspension culture
with a core of unorganized cells and a surface layer of
elongated cells (Fig. 2 
 
C
 
). After 7 d, KOP spheroids con-
sisted of a core of dead cells with numerous apoptotic bod-
ies and several layers of elongated viable surface cells in-
dicative of an attempt to form a multilayered epithelium
(Fig. 2 
 
D
 
). As control tumor cells that have been widely
used in spheroid experiments (for example see reference
46), we used C6 glioma cells. As expected, these cells
readily form multicellular aggregates within hours. They
do, however, fail to organize and form a uniform mass of
cells (Fig. 2 
 
E
 
). After prolonged periods of culture, C6
glioma spheroids develop a necrotic center surrounded
by several layers of viable but unorganized surface cells
(Fig. 2 
 
F
 
).
Figure 1. Formation of a standard spheroid of BAE cells. A de-
fined number of cells (3,000) was seeded in nonadhesive 96-well
round-bottom plates. As cells sediment over time, they aggregate
within 2Ð4 h after which they remodel to form a compact rounded
spheroid within 18 h. Essentially all suspended cells contribute to
the formation of a single spheroid. Similar results are obtained
with HUVEC. Bar, 200 mm. 
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Integration of EC in the Organized Spheroid
Surface Monolayer Induces Polar Endothelial Cell 
Differentiation and Cellular Quiescence
 
The initial series of experiments had indicated that EC
maintained in suspension in three-dimensional spheroids
organize spontaneously to develop a two compartment
system consisting of a surface layer of differentiated cells
and a core of unorganized cells that disappear over time.
Differentiation into a two compartment system could be
confirmed by ultrastructural analyses of cultured endothe-
lial cell spheroids. The surface layer of cells was found to
consist of a continuous monolayer of elongated cells (Fig.
3 
 
A
 
). Well-differentiated cellÐcell contacts with parallel
electron dense strands were indicative of the formation of
tight junctions (Fig. 3 
 
B
 
) that indicated a high degree of
cellular differentiation (30). Numerous apoptotic bodies
were present in the center of the spheroids (Fig. 3 
 
C
 
) as
well as in surface EC that had failed to integrate into the
surface monolayer (Fig. 3 
 
A
 
, 
 
arrows
 
).
To assess the degree of cellular quiescence of spheroid
EC compared with monolayer EC, we determined the
fraction of proliferating cells using BrdU labeling. EC in
the spheroid center showed no detectable incorporation of
BrdU. In contrast, EC in the surface monolayer of 1 d
spheroids had a very low labeling index (BAEC: 0.97 
 
6
 
1.43%; HUVEC: 0.08 
 
6 
 
0.35%) that declined to undetect-
able levels within 5 d. In comparison, cultured monolayer
EC had much higher BrdU labeling indices even when
analyzing cell populations that were cultured for an
additional day after acquiring confluence (BAEC [sub-
confluent]: 72.6 
 
6 
 
8.8%; BAEC [confluent]: 9.0 
 
6 
 
1.6%;
HUVEC [subconfluent]: 48.7 
 
6 
 
7.9%; HUVEC [conflu-
ent]: 8.6 
 
6 
 
3.3%).
 
Organized Surface Spheroid EC Can Be Induced to 
Express Differentiation and Activation Antigens
 
We next studied the capacity of spheroid EC to express
differentiation and activation antigens. For these experi-
ments, 1-d spheroids were incubated with various cyto-
kines and the expression of CD31 (PECAM-1), ICAM-1,
VCAM-1, and CD34 was analyzed cytochemically. Most
of the spheroid EC expressed the panendothelial cell sur-
face molecule CD31 (Fig. 4 
 
A
 
). Expression was most in-
tense in the cells closest to the spheroid surface and gradu-
ally declined towards the spheroid center. The center EC
expressed CD31 uniformly on the cell surface. In contrast,
Figure 2. Differentiation of endothelial cell spheroids (A and B)
compared with spheroids generated from esophageal epithelial
cells (C and D) and C6 glioma cells (E and F). (A) 1-d BAEC
spheroid with surface layer of elongated cells and a core of unor-
ganized cells and apoptotic bodies. (B) 7-d BAEC spheroids with
surface monolayer and an almost acellular core. (C) 1-d KOP cell
spheroid. (D) 7-d KOP cell spheroids with multilayered elon-
gated surface cells and a core of unorganized cells with numerous
apoptotic bodies. (E) 1-d C6 glioma spheroid. (F) 7-d C6 glioma
spheroids with a necrotic center and a peripheral ring of viable,
but undifferentiated surface cells. Bar, 50 mm.
Figure 3. Ultrastructural analysis of a 5-d BAEC spheroid. (A)
BAEC spheroids consist of a fully differentiated and polarized
surface layer of cells and a core of unorganized cells. The surface
cells form a continuous monolayer that may develop electron
dense strands indicative of tight junctional cellÐcell contacts
(magnification in B). The center cells undergo apoptosis as evi-
denced by the presence of numerous apoptotic bodies (magnifi-
cation in C). Likewise, cells on the spheroid surface that did not
integrate into the monolayer undergo apoptosis (A,  arrows).
Bars: (A and C) 10 mm; (B) 0.5 mm. 
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the surface layer of EC expressed CD31 selectively at lat-
eral and basal cellÐcell contacts and only minimally on the
luminal cell surface. Cytokine stimulation experiments
with FGF-2, VEGF, IL-1, and TNF-
 
a
 
 did not affect endo-
thelial CD31 expression in multicellular spheroids (Fig. 5).
IL-1 and TNF-
 
a
 
 stimulation of endothelial cell spher-
oids was capable to induce surface expression of inducible
endothelial cell adhesion molecules such as ICAM-1
(CD54) and VCAM-1 (CD106). As shown in Fig. 4, 
 
B
 
(ICAM-1) and 
 
C
 
 (VCAM-1) expression of these mole-
cules was limited to the differentiated surface layer of the
spheroids. These cells expressed ICAM-1 and VCAM-1
selectively on the luminal cell surface.
Based on these experiments, we next asked if other dif-
ferentiation antigens of EC could be induced in spheroid
culture. CD34 is a surface molecule that is expressed by
most EC in vivo (9). However, upon transfer of cells in
culture endothelial cell CD34 expression is rapidly down-
regulated (16). Endothelial cell CD34 expression can be
maintained to some extend by restraining cell prolifera-
tion and promoting cell contact (16). However, no cyto-
kines or specific microenvironmental requirements have
been characterized that are capable to upregulate endo-
thelial CD34 expression. Spheroid EC that were generated
from EC previously maintained in two-dimensional mono-
layer culture expressed barely detectable levels of CD34
(Fig. 4 
 
D
 
). Exposure of spheroids to different cytokines re-
vealed that VEGF is capable to prominently induce endo-
thelial cell CD34 expression (Fig. 4 
 
E
 
). Expression is lim-
ited to the surface layer of EC. However, in contrast to the
polar expression of CD31, ICAM-1, and VCAM-1 by the
surface cells CD34 is uniformly expressed on the cell sur-
face of the responsive cells. The induction of endothelial
CD34 expression was found to be a VEGF specific effect
as other cytokines failed to induce CD34 expression (Fig.
5). Exposure of VEGF-treated spheroids to TNF-
 
a
 
 led to
a complete downregulation of CD34 expression in spher-
oid EC (data not shown). Finally, the responsiveness to
VEGF in the induction of CD34 was found to be critically
microenvironment dependent since it could be observed in
spheroid culture (Fig. 4 
 
E
 
) and only to a lesser degree in
monolayer culture (Fig. 4, 
 
F
 
 vs. 
 
G
 
). The microenviron-
ment dependency of VEGF-mediated CD34 expression
was also indicated by the fact that 2-d spheroids were
more responsive to VEGF stimulation than 1-d spheroids
(data not shown).
 
Spheroid Organization Is Dependent on
Integrin-mediated CellÐMatrix Contacts That Are 
Crucial for the Survival of the Organized
Surface Spheroid EC
 
To identify adhesive interactions of the surface monolayer
cells that might be responsible for preventing these cells
from undergoing apoptosis, endothelial cell spheroids
were treated with RGD peptides or control RAD peptides
(30 
 
m
 
M) to inhibit integrin-dependent adhesive interac-
tions. Quantitative analysis of apoptosis using the DNA
fragmentation ELISA indicated a significant increase in
total EC apoptosis in RGD-treated spheroids (
 
P
 
 , 
 
0.01;
RGD-treated vs. untreated control: 216.1 
 
6 40.1%; RAD-
treated vs. untreated control: 113.8 6 15.3%). To qualita-
tively trace apoptotic cells, apoptosis was monitored using
TUNEL staining (Fig. 6 A) or staining with ethidium bro-
mide (Fig. 6 B). As indicated in Fig. 6 D, treatment of
spheroids with RGD peptides led to apoptosis of the sur-
face monolayer EC as well as to an increased level of
apoptosis in the center of the spheroids. If maintained in
suspension culture, RGD-treated endothelial cell spher-
oids gradually lost all signs of differentiation and began to
fall apart (Fig. 6 F). In contrast, control RAD revealed the
specificity of the RGD mediated antiadhesive effects dem-
onstrating intact spheroids (Fig. 6 E) without apoptosis of
the surface cells (Fig. 6 C).
Figure 4. Expression of endothelial cell surface adhesion mole-
cules by HUVEC spheroids. (A) Most spheroid EC express the
panendothelial cell marker CD31. (B) Expression of ICAM-1 in
HUVEC spheroids after stimulation with TNF-a for 24 h. (C)
Expression of VCAM-1 in HUVEC spheroids after stimulation
with TNF-a for 24 h. (D) Untreated HUVEC spheroids express
barely detectable levels of CD34. (E) Expression of CD34 in
HUVEC spheroids after stimulation with VEGF for 24 h. (F and
G) Expression of CD34 in cross sections of harvested HUVEC
monolayer embedded in paraffin as single cells. CD34 expression
is downregulated in two-dimensional culture (F). Stimulation of
monolayer cultures with VEGF only minimally increases the
number of CD34-positive cells (G). Bar, 50 mm.The Journal of Cell Biology, Volume 143, 1998 1346
Center Spheroid EC Do Not Differentiate and Are 
Dependent on Survival Factors to Prevent Apoptosis
The experiments performed so far had indicated that apop-
tosis of the center EC will eventually lead to the formation
of a spheroid with an acellular core. We, thus reasoned
that the unorganized center spheroid cell population
might be a suitable target cell population to study the
effects of endothelial survival factors. VEGF and FGF-2
regulate numerous critical endothelial cell functions and
both of these cytokines have been proposed to act as en-
dothelial survival factors (1, 11, 27, 43, 47, 53).
Treatment of HUVEC spheroids with VEGF and FGF-2
significantly inhibited apoptosis of center spheroid EC
(Fig. 7, A, C, and D). VEGF (100 ng/ml) and FGF-2 (30
ng/ml) exerted additive effects reducing spheroid endothe-
lial cell apoptosis by .50% (Fig. 7 A). Treatment with a
neutralizing monoclonal a-FGF-2 antibody increased cen-
ter endothelial cell apoptosis above the already high base-
line levels (Fig. 7 A). Exogenous VEGF rescued from neu-
tralizing a-FGF-2 antibody mediated increased apoptosis
to a similar degree as would be expected from the ob-
served additive effects of VEGF and FGF-2 (Fig. 7 A). In
contrast, addition of a neutralizing a-VEGF antibody had
no effect on baseline apoptosis, suggesting that FGF-2 and
not VEGF is capable of controlling survival of immature
EC in an autocrine manner.
Similar, albeit qualitatively different results were ob-
tained in the analysis of VEGF and FGF-2 mediated sur-
vival effects on BAE cells. Compared with HUVEC, BAE
cells had a much lower baseline rate of apoptosis (Fig. 7, E
vs.  C). BAE cell behavior in culture is known to be
strongly influenced by the endogenous expression of FGF-2
and BAEC have, thus, been widely studied to assess FGF-2
mediated autocrine endothelial cell growth control (35, 51,
56). Corresponding to these findings, strongest effects on
the survival of BAEC in spheroids were observed when
BAEC spheroids were treated with a neutralizing a-FGF-2
antibody (4 mg/ml) that increased endothelial cell apopto-
sis by 60% (Fig. 7, B and E vs. F). Treatment with a neu-
tralizing a-FGF-2 antibody affected the center cells and
not the differentiated cells of the surface monolayer (Fig. 7
F). Corresponding to the induction of endothelial cell
apoptosis by neutralizing a-FGF-2 antibody, addition of
exogenous FGF-2 further reduced baseline endothelial
cell apoptosis by .30%. Addition of exogenous VEGF or
neutralizing a-VEGF antibody had no effect on BAEC
survival in spheroids (Fig. 7 B), despite the fact that
BAEC in spheroids expressed VEGF-R1 (Flt-1) and
VEGF-R2 (Flk-1/KDR; data not shown). Surprisingly and
much in contrast to the additive effect of VEGF and FGF-2
in HUVEC, VEGF attenuated the exogenous FGF-
2Ðmediated reduction of baseline BAE cell apoptosis (Fig.
7 B). This effect was reproducibly observed in all experi-
ments. Several studies have indicated synergistic activities
of VEGF and FGF-2 on endothelial cell function (3, 22,
38) and some reports even suggest that VEGF and FGF-2
mediated activities are functionally dependent on each
other (33, 48). In light of these recent findings, the molecu-
lar basis of the observed differences in the responsiveness
of the two cell populations to VEGF is focus of ongoing
experiments that may well shed further light into the
mechanistic functional interaction of VEGF and FGF-2.
The survival mediating effect of VEGF and FGF-2 was
analyzed in 24 h short-term experiments. To verify if exog-
enous survival factors could rescue the center spheroid
cells for prolonged periods of time, spheroids of HUVEC
and BAE cells were either incubated with VEGF and
FGF-2 or with neutralizing antibodies to these cytokines
for 4 d. Reflecting their low baseline autocrine activity,
HUVEC spheroids cultured for 4 d without exogenous
Figure 5. Summary of expression pattern of endothelial cell adhesion molecules in monolayer culture and spheroids. EC constitutively
express CD31. Intensity of expression does not change after cytokine stimulation. Stimulation of EC with IL-1 or TNF-a induces expres-
sion of ICAM-1 and VCAM-1, which is in the spheroids limited to the luminal aspect of the surface monolayer. CD34 is only expressed
after VEGF stimulation. The induction of CD34 by VEGF is dependent on the differentiation status of the cells and their microenviron-
ment as it is only inducible in spheroid EC and only minimally in monolayer cells.Korff and Augustin Endothelial Cells in Multicellular Spheroids 1347
survival factors consisted of an almost acellular core and a
differentiated surface monolayer (Fig. 8 A). In contrast,
HUVEC spheroids continuously maintained in 50 ng/ml of
VEGF and 30 ng/ml of FGF-2 had a core of viable EC
(Fig. 8 C). BAEC spheroids had a higher rate of auto-
crine activity as indicated by a lower baseline rate of
center  spheroid cell apoptosis. After 4 d in culture without
exogenous survival factors, BAEC spheroids had a dif-
ferentiated surface monolayer and a center of still viable
unorganized cells along with numerous dying cells with
condensed apoptotic bodies (Fig. 8 B). Addition of a neu-
tralizing a-FGF-2 antibody led to an increase in the rate of
apoptosis of the center spheroid BAE cells, but did not af-
fect the survival of the monolayer BAE cells (Fig. 8 D).
This observation provided additional evidence for the no-
tion that the cells of the surface monolayer matured to a
degree that rendered them independent of the activities of
exogenous as well as endogenous survival factors.
Single Suspended EC Die by Apoptosis and Can Not Be 
Rescued by Exogenous Survival Factors
The experiments described above had indicated that the
center spheroid EC were the target cell population of the
activities of endothelial survival factors. Consequently, we
next studied the responsiveness of single suspended EC to
exogenously administered survival factors. Inhibition of
anchorage-dependent cell spreading of single cells has pre-
viously been demonstrated to trigger apoptosis of cultured
EC (40). Corresponding to these findings, single suspended
EC (nonadhesive tissue culture dishes, high concentra-
tions of methocel) were not capable to survive and died
within hours (HUVEC) and days (BAEC), respectively.
Viability of EC in suspension culture was assessed by
quantitating their adhesiveness after transfer to adhesive
tissue culture dishes (Fig. 9 A). The reduction in endothe-
lial cell readhesiveness after transfer to adhesive tissue
culture dishes was paralleled by massive nucleosomal frag-
mentation as evidenced by DNA laddering that suggested
that the nonadhesive cells died by apoptosis (Fig. 9 B).
Based on these observations, we exposed single suspended
EC to the survival factors that had proved to be effective
in spheroid culture. As shown in Fig. 9 C and correspond-
ing to recent studies with FGF-2 (27), none of the treat-
ments (VEGF and FGF-2 alone or in combination) af-
fected the rate of apoptosis of single suspended EC
suggesting that these cells are not responsive to the sur-
vival factor activities of VEGF and FGF-2.
CellÐCell Contacts of Unorganized EC are a 
Prerequisite for Survival Factor Responsiveness
To identify parameters that mediate the responsiveness of
EC to survival factors, we assessed the responsiveness of
single and aggregated EC to survival factors after treat-
ment of the cells with cytochalasin D. The rationale of
these experiments was based on the idea that cytochalasin
DÐtreated cells are still able to establish cellÐcell contacts.
Disruption of the cytoskeleton does, however, inhibit
three-dimensional spheroidal organization. The experi-
ment was consequently aimed at answering if cellÐcell con-
tacts are sufficient to mediate endothelial survival factor
responsiveness or if the complex cellular interactions in-
cluding shape changes as they occur in the center of the
spheroids would be required to mediate survival factor re-
sponsiveness.
As shown in Fig. 10 A, cytochalasin D treatment during
HUVEC spheroid formation did not affect the rate of
apoptosis. As expected, however, cytochalasin D treat-
ment prevented spheroid formation leaving an aggregate
of loosely adherent cells that failed to organize three-
dimensionally (Fig. 10, C vs. B). Cytochalasin DÐtreated
cellular aggregates were responsive to the survival factor
activities of exogenously administered VEGF and FGF-2
(Fig. 10 A) reducing HUVE cell apoptosis by z50% (P ,
Figure 6. Analysis of endothelial cell apoptosis in 1-d BAEC
spheroids. Apoptosis of EC was detected either by TUNEL stain-
ing (A, random spheroids) or by ethidium bromide staining (B,
standard spheroid; calcein AM used as surface stain). Both tech-
niques led to similar results. Apoptosis of BAE cells is limited to
the cells in the center of the spheroids (A and B) as well as to sur-
face BAE cells that have not integrated into the surface mono-
layer (A and B, arrows). (C) Treatment of BAEC spheroids with
RAD peptides (30 mM) does not affect endothelial cell apoptosis
([E] hematoxylin-stained sectioned RAD-treated spheroid). (D)
Treatment of BAEC spheroids with RGD peptides (30 mM) for
24 h leads to a disruption of the integrity of the surface mono-
layer and induces surface cell apoptosis ([F] hematoxylin-stained
sectioned RGD-treated disintegrating BAEC spheroid). Bar,
50 mm.The Journal of Cell Biology, Volume 143, 1998 1348
0.05). In contrast, deprivation of Ca11-dependent cellular
adhesion by EGTA treatment inhibited cellular aggrega-
tion and, thus, left the cells unresponsive to the activities
of survival factors (Fig. 10 A). Taken together, the data in-
dicate that cellÐcell contacts are a requisite for rendering
EC survival factor responsive.
Discussion
Three-dimensional tissue culture systems have been used
widely in the context of tumor cell biology (7, 31, 36, 49).
Likewise, the differentiation of individual cell types in
three-dimensional cultures of embryonic stem cells has
contributed to the understanding of cell lineages and dif-
ferentiation phenomena (10, 29, 52). Spheroid cultures of
embryonic stem cells can be used for the organotypic dif-
ferentiation of EC in embryoid bodies that are lined by a
peripheral layer of angioblastic cells and a core of hemato-
poietic cells (10, 52). We, thus, hypothesized that spheroid
cultures of nontransformed EC may provide a suitable dif-
ferentiation model to study differentiated endothelial cell
functions.
EC maintained in suspension cultures under conditions
that allow cellular aggregation readily form three-dimen-
sional spheroids. However, in contrast to tumor cell spher-
oids endothelial cell spheroids organize to establish a two
compartment system consisting of a surface monolayer of
differentiated cells and a center of unorganized cells that
will die by apoptosis if they are not rescued by survival fac-
tors. This organoid differentiation is not restricted to EC.
Instead, we observed that nontransformed epithelial cells
that grow as a monolayer in two-dimensional culture form
a multilayered epithelium in three-dimensional spheroid
culture suggesting that spheroid culture techniques may be
used to study differentiation phenomena of a variety of
different nontransformed cell types.
We used the endothelial cell spheroid differentiation
model to trace the fate of the unorganized center EC and
their responsiveness to survival factors as well as the dif-
ferentiation capacity of the surface monolayer. The data
support a model of endothelial cell organization and dif-
ferentiation in spheroid culture that is summarized in Fig.
11. Single suspended EC are not capable to survive and
rapidly die by apoptosis. They are not responsive to the ac-
tivities of survival factors. Spheroidal aggregation of EC
mediates cellÐcell contacts and renders the cells survival
Figure 7. Quantitative (A and B) and qualitative (CÐF) analysis of endothelial cell apoptosis (A, C, and D, HUVE cells; B, E, and F,
BAE cells) after treatment with different cytokines. (A and B) A defined number of spheroids was stimulated with different cytokines
for 24 h and the presence of nucleosomal fragmentation products was quantitated by ELISA (see Materials and Methods). Data are ex-
pressed as percentage deviation of the level of apoptosis from the untreated control spheroid population (shown in C [HUVEC] and E
[BAEC]). The figure shows the mean 6 SEM of three different experiments performed in duplicate (*P , 0.05; **P , 0.01). (C) con-
trol HUVEC spheroid; (D) VEGF 1 FGF-2 stimulated HUVEC spheroid. (E) control BAEC spheroid treated with isotype matched
nonneutralizing monoclonal antibody to FGF-2 (4 mg/ml). (F) BAEC spheroid treated with neutralizing monoclonal antibody to FGF-2
[4 mg/ml]). Bar, 50 mm.Korff and Augustin Endothelial Cells in Multicellular Spheroids 1349
factor responsive. Survival factor responsiveness is medi-
ated by cellÐcell contacts and does not require cell shape
changes. Upon spheroid organization, the surface cells es-
tablish a polarized elongated continuous monolayer. The
differentiation characteristics of this surface monolayer
goes beyond the degree of differentiation that can be ob-
tained in two dimensional culture. This conclusion is sup-
ported by (a) the observed polarized expression of endo-
thelial cell surface molecules (basal and lateral expression
of CD31; luminal expression of ICAM-1 and VCAM-1),
(b) the ultrastructural characteristics of the surface mono-
layer with well developed cellÐcell contacts, (c) the promi-
nent induction of surface molecules that can only min-
imally be induced in two-dimensional culture systems
(VEGF mediated induction of CD34), and (d) the lower
turnover rates of spheroid surface EC compared with con-
fluent monolayer EC reflecting a higher degree of cellular
quiescence. Finally, if EC spheroids are not exposed to
survival factors, the center cells completely undergo apop-
tosis leaving an EC spheroid consisting of an acellular core
and a surface monolayer that has become independent of
the activities of survival factors.
One of the most surprising findings of this study was the
observed regulation of endothelial cell CD34 expression
by VEGF. CD34 is a differentiation antigen expressed by
most EC in vivo that is downregulated upon transfer of
cells into standard in vitro cell culture systems (9, 16, 17,
20). Endothelial cell CD34 expression has been reported
to be reciprocally regulated to the expression of inflamma-
tion associated endothelial cell adhesion molecules (16).
Likewise, expression of CD34 has been shown to be up-
regulated by EC during angiogenesis (25, 57). Both find-
ings are compatible with the observed regulation of CD34
by VEGF. More intriguingly, however, CD34 has been
characterized as a marker of hemangioblastic stem cells,
which is downregulated in the hematopoietic lineage and
maintained in the angioblastic lineage (4, 25, 57). This ex-
pression pattern parallels the expression of VEGF-R2
(KDR/Flk-1), which is similarly expressed by hemangio-
blastic stem cells being downregulated in the hematopoi-
etic lineage and not in the angioblastic lineage (55). CD34
has functionally been characterized as a ligand for L-selec-
tin (8, 39), but the function of its endothelial cell expres-
Figure 8. Effect of long-term treatment (4 d) of EC spheroids
with the survival factors VEGF and FGF-2 and a neutralizing
monoclonal antibody to FGF-2. Cytokines and antibodies were
added at the beginning of the experiment and again after 2 d.
Spheroids were analyzed after 4 d. (A) control HUVEC spheroid.
(B) Control BAEC spheroid. (C) HUVEC spheroid treated with
VEGF (50 ng/ml) and FGF-2 (30 ng/ml). (D) BAEC spheroid
treated with a neutralizing monoclonal antibody to FGF-2 (4 mg/ml).
Bars: (A and C) 30 mm; (B and D) 50 mm.
Figure 9. Analysis of the fate of single nonadherent EC and of their responsiveness to exogenously administered survival factors. The
experiments shown were performed with HUVEC, similar results were obtained with BAE cells. (A) HUVEC were grown at low seed-
ing density in nonadhesive tissue culture dishes in the presence of high concentrations of methocel to prevent cellular aggregation (see
Materials and Methods). The cells were transferred to adhesive tissue culture dishes after the indicated periods of time and the number
of adherent cells per microscopic field of view (MFV) was quantitated after 2 h. Adherence was quantitated by counting the cells that
had adhered as single cells (gray bars) and the cells that had adhered in clustered groups that was indicative of cellular aggregation in
the methocel medium (black bar). The data shown represent the mean 6 SD of three independent experiments performed in triplicate.
(B) The reduction of single cell readhesiveness as shown in A is paralleled by a pronounced increase of single cell apoptosis as evi-
denced by intense DNA laddering. (C) Quantitation of nucleosomal fragmentation by ELISA (see Materials and Methods) to analyze
the responsiveness of single suspended HUVEC to exogenously administered survival factors.The Journal of Cell Biology, Volume 143, 1998 1350
sion has not been well defined. Likewise, analysis of the
phenotype CD34 deficient mice has not been very instruc-
tive in defining the function of endothelial cell CD34 ex-
pression (14).
In addition to studying the differentiation of the surface
endothelial monolayer, the endothelial cell spheroid model
proved to be useful to analyze the functions and to charac-
terize the phenotypic properties of the target cell popula-
tion of endothelial survival factors. A number of elegant in
vivo studies have demonstrated the dependence of EC in
immature capillaries on exogenous survival factors (1, 11).
VEGF appears to play a central role as endothelial sur-
vival factor as was originally demonstrated in the imma-
ture retinal vasculature of newborn rats (1). Likewise, the
sudden downregulation of VEGF in conditionally VEGF
overexpressing tumors leads to a collapse of the vascula-
ture with detachment and subsequent apoptosis of imma-
ture capillary EC (11). Several in vitro studies have pro-
vided additional evidence for the central role of VEGF in
acting as an endothelial survival factor (43, 47, 53) and
VEGF has also been proposed to act as survival factor for
hematopoietic stem cells (28).
This study employed the endothelial cell spheroid model
to analyze the survival mediating activities of VEGF and
FGF-2. The data indicate that both VEGF and FGF-2 are
capable to act as endothelial survival factors with endoge-
nous expression of FGF-2 playing a critical role as an auto-
crine growth factor in regulating endothelial cell survival.
More importantly, this study could characterize the pheno-
type of EC that is responsive and dependent on survival
factors. Single suspended EC can only survive for short pe-
riods of times and are not responsive to survival factors.
Circulating hematopoietic cells as well as the recently char-
acterized circulating angioblastic stem cell (4) can survive
without cellÐcell contacts or anchorage dependence and
are apparently not dependent on survival factors. Corre-
spondingly, techniques have been described to differenti-
ate EC from circulating angioblastic cells using VEGF and
adhesion to fibronectin as selection and differentiation
pressure (4). In light of the findings presented in this study,
it will be interesting to see at which stage of differentiation
angioblastic cells become survival factor dependent.
In contrast to the survival factor dependence of the un-
organized cells in the spheroid center, the cells of the sur-
face monolayer differentiated to a degree that rendered
them survival factor independent. A number of studies
have demonstrated that cellular functions including cell
survival depend on the tensional integrity (tensegrity) of Figure 10. Analysis of the effect of cytochalasin D treatment on
VEGF and FGF-2 mediated survival factor activities in HUVEC
spheroids (quantitation by ELISA; see Materials and Methods;
results [mean 6 SD of three independent experiments performed
in duplicate] are expressed in% of the maximum). (A) Cytochala-
sin D treatment (5 mg/ml) does not affect apoptosis of aggregated
EC. (B) Control HUVEC spheroid. (C) HUVEC aggregation af-
ter cytochalasin D treatment. Cytochalasin DÐtreated HUVEC
are responsive to the survival factor activities of VEGF and FGF-2.
Treatment of cells with EGTA (5 mM, 24 h) disrupts calcium-
dependent cellÐcell contacts resulting in highest levels of apopto-
sis. In contrast to cytochalasinÐtreated aggregated cells with cellÐ
cell contacts, EGTA-treated single cells are not responsive to
VEGF and FGF-2.
Figure 11. Model of endothelial cell organization and differenti-
ation in three-dimensional spheroids. Single suspended EC are
neither capable to survive nor responsive to the activities of sur-
vival factors and die by apoptosis (anoikis; apoptosis as a conse-
quence of a loss of matrix anchorage). EC that aggregate to
form three-dimensional spheroids establish cellÐcell contacts
that renders the cell survival factor responsive. Subsequently,
nontransformed EC in spheroids organize to establish a two com-
partment system consisting of a peripheral surface monolayer of
differentiated, polarized, survival factorÐindependent cells, and a
core of survival factorÐdependent unorganized cells. If not con-
tinuously exposed to survival factors, the center EC will die by
apoptosis to produce a three-dimensional spheroid that consists
of an acellular core and a differentiated surface monolayer of EC.Korff and Augustin Endothelial Cells in Multicellular Spheroids 1351
the cells that is directly affected by the shape of the cells
(13, 42). Likewise, the endothelial cell extracellular matrix
does not only act as a morphogenetic regulator (24), but is
also known to mediate survival signals (34) that involves
integrin mediated signaling (19, 42, 44, 50). Integrin-medi-
ated signal transduction is known to be at least partially
controlled by cell shape as evidenced by the inability of
RGD-coated beads to inhibit apoptosis of rounded non-
adherent EC (40). Corresponding to these findings, the
unorganized center spheroid cells are surrounded by ex-
tracellular matrix components and fail to organize into a
polarized elongated monolayer. CellÐcell contacts may
render these cells survival factor responsive, but not sur-
vival factor independent. In contrast, the surface cells of
the spheroids grow on an extracellular matrix and differ-
entiate to form a polarized monolayer of elongated cells
that has become survival factor independent. The nature
of the survival mediating extracellular matrix in vivo and
in vitro remains to be elucidated but it appears that endo-
thelial cell spheroids offer a useful approach to this end.
Recent experiments have suggested that pericyte contact
renders EC survival factor independent as long as the cell
are exposed to a provisional matrix (12). According to
these findings, synthesis of a mature extracellular matrix is
a critical step in vessel wall assembly and endothelial cell
maturation.
Taken together this study has developed a spheroid
model for the analysis of specific differentiation phenom-
ena of EC as well as the functions of endothelial survival
factors. It is concluded that spheroid models of nontrans-
formed cells are not just applicable to the analysis of dif-
ferentiated endothelial cell functions, but that they may
prove to be powerful tools to study the differentiation of
numerous other nontransformed cell types. Likewise, the
endothelial cell spheroid model may prove to be useful for
a number of other aspects of endothelial cell differentia-
tion such as three-dimensional angiogenic maturation
(Korff, T., and H.G. Augustin, manuscript in preparation),
regulation of endothelial cell surface receptor expression,
and the analysis of cellular interactions of EC with mural
cells. Finally, the described techniques to generate endo-
thelial cell spheroids of defined size may prove to be use-
ful for therapeutic strategies aimed at reintroducing genet-
ically manipulated EC into specific capillary beds after
similar experimental approaches as have been described
for the microsphere mediated delivery of angiogenic cy-
tokines to sites of cardiac ischemia (2).
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